Maryland Bill Would Defy FDA, Allow Experimental Treatments for Terminally-Ill
ANNAPOLIS, Md. (Feb. 6, 2017) – A bill introduced in the Maryland House would the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584 (HB584) would give terminally ill…